Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: journeymedicalcorp.com (DERM)

Journey Medical Corp. - logo grafis emiten DERM

The investment attractiveness of Journey Medical (DERM) is based on its in-house production of dermatological products and established distribution channels. The quarterly earnings per share (EPS) growth trend on the GURU.Markets chart confirms this, where 50.20 represents the latest metric reading. Growth is driven by the scaling of Emrosi sales, while independence from macroeconomic factors makes the asset a defensive tool during market downturns.

Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Journey Medical Corporation (DERM): kanggo periode 04.07.2022 - 15.11.2026

DERM (Journey Medical Corporation): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Journey Medical
Produk dadi journeymedicalcorp.com

The fundamental resilience of the business is determined by its ability to generate net income per share. This indicator captures the percentage change in profit per quarter, reflecting the efficiency of cost management. For Journey Medical (DERM), this is a critical marker of the transition to profitability while scaling sales of the rosacea drug. B2B distribution dynamics directly impact the bottom line. By analyzing this quarterly EPS chart, an investor can see the actual pace of commercial expansion.

Pesaing wigati

KRYS: Wutah bathi EPS kuartalan|APGE - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Arcutis Biotherapeutics, Inc.|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan VCEL (Vericel)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Oruka Pharma (ORKA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Sanara MedTech|Wutah bathi EPS kuartalan DBVT (DBV Technologies SA)|Solesence Inc (SLSN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|FBRX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan EMPG|SLGL (sol-gel.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|AXIL (AXIL Brands, Inc.) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|MDCX (Medicus Pharma Corp) - Wutah bathi EPS kuartalan|Verrica Pharmaceuticals (VRCA) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HOTH (Hoth Therapeutics, Inc.)|BFRI - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan VYNE (VYNE Therapeutics)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan SNOA|Quoin Pharmaceuticals Ltd. - Wutah bathi EPS kuartalan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Azitra Corporation AZTR|DRMA (Dermata) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Elevai Labs Inc. (ELAB) - Wutah bathi EPS kuartalan|RVNC (Revance Therapeutics, Inc.) - Wutah bathi EPS kuartalan